Amneal Pharmaceuticals, Inc. is a global pharmaceutical company. Our team of 7,500+ colleagues helps make healthy possible through the development, manufacturing, and distribution of a diverse portfolio of 270+ high- quality medicines.

Looking for candidates with relevant experience in injectable regulated plant as mentioned below

Post : Apprentice Associate / Sr. Assistant / Assistant 

Positive high-level results from the EMERALD-3 Phase III trial showed AstraZeneca’s Imfinzi (durvalumab) in combination with Imjudo (tremelimumab), lenvatinib and transarterial chemoembolisation (TACE) demonstrated a statistically significant and clinically meaningful improvement in the primary endpoint of progression-free survival (PFS) versus TACE alone for patients with unresectable hepatocellular carcinoma (HCC) eligible for embolisation.

In a significant step toward easing the regulatory burden on India's retail pharmacy sector, the Drugs Consultative Committee (DCC) at its 68th meeting on 20 March 2026 directed a sub-committee to examine four landmark deregulation proposals. The sub-committee's findings will be placed before the DCC for final deliberation before any rule amendments are made.

Eli Lilly and Company announced the U.S. Food and Drug Administration (FDA) approved Foundayo™ (orforglipron) for adults with obesity, or overweight with weight-related medical problems.

When used alongside a reduced-calorie diet and increased physical activity, Foundayo helps individuals lose excess body weight and keep the weight off. Foundayo will be available via LillyDirect®, with prescriptions accepted immediately and shipping beginning April 6, followed shortly after by broad availability through U.S. retail pharmacies and telehealth providers.

Director, Chittaranjan National Cancer Institute, invites applications for the post of one Research Associate I in the Ministry of Ayush sponsored project entitled “Role of Homoeopathic Medicines in Chemotherapy: improvising chemo-sensitivity in colon cancer” under Dr. Nabanita Chattertjee (Principal Investigator) in the Department of Receptor Biology and Tumor Metastasis, CNCI (Hazra Campus).

Post : Research Associate I (One Post)